Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease

Abstract

Alzheimer's disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood-brain barrier. Nanotechnological treatment methods, which involve the… (More)
DOI: 10.2147/IJN.S87148

Topics

7 Figures and Tables

Cite this paper

@inproceedings{FonsecaSantos2015NanotechnologybasedDD, title={Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease}, author={Bruno Fonseca-Santos and Maria Palmira Daflon Gremi{\~a}o and Marlus Chorilli}, booktitle={International journal of nanomedicine}, year={2015} }